GlassScriptPhysician profile
Jose R Chamorro
NPI 1376978460
$15,274.09
in general payments reported to CMS, 2019-2025
35 companies · $4,518 in 2025
The $4,518 reported for 2025 was more than what 98% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,253 · 2022: $3,004 · 2023: $3,931 · 2024: $2,568 · 2025: $4,518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,171 · Travel and Lodging: $2,801 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,171.14 |
| Travel and Lodging | $2,800.64 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $3,225.67 | 2021-2025 | Biomonitor, Renamic Neo, Rivacor 7 Dr-T |
| Medtronic, INC. | $2,661.78 | 2021-2025 | Linq II, Micra |
| Astrazeneca Pharmaceuticals LP | $1,601.53 | 2021-2025 | Farxiga, Wainua, Lokelma |
| Abbott Laboratories | $1,545.83 | 2021-2025 | Aveir, Jot Dx, Gallant |
| Boston Scientific Corporation | $1,019.31 | 2022-2025 | Watchman Access System, Emblem Mri S-Icd, Watchman Flx |
| Impulse Dynamics (USA) INC. | $670.01 | 2021-2025 | Optimizer, Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $508.84 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $432.02 | 2021-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $390.95 | 2021-2025 | Camzyos |
| Amgen INC. | $371.98 | 2021-2025 | Repatha, Repatha |
| Novo Nordisk INC | $366.25 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Actelion Pharmaceuticals US, INC. | $310.85 | 2021-2025 | Opsumit, Uptravi |
| Novartis Pharmaceuticals Corporation | $309.24 | 2021-2025 | |
| Pfizer INC. | $307.71 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $216.18 | 2022-2025 | Verquvo |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $212.40 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $175.13 | 2022-2025 | |
| Lexicon Pharmaceuticals, INC. | $122.10 | 2023 | Inpefa |
| Bridgebio Pharma, INC. | $120.42 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $84.19 | 2022-2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $58.38 | 2021-2023 | |
| Amarin Pharma, INC. | $58.31 | 2021-2022 | |
| Baxter Healthcare | $56.30 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $50.06 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $49.56 | 2024-2025 | Onpattro, Amvuttra |
| Atricure, INC. | $45.29 | 2023 | |
| Irhythm Technologies, INC. | $44.98 | 2024 | Zio Monitor, Zio Xt Patch |
| Philips North America LLC | $43.80 | 2025 | Diagnostic Ecg Service |
| Sumitomo Pharma America, INC. | $41.65 | 2024-2025 | Gemtesa |
| Kiniksa Pharmaceuticals, LTD. | $39.14 | 2021-2023 | Arcalyst |
| Angiodynamics, INC. | $33.33 | 2023 | Auryon Laser System 100-120 Vac |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.20 | 2025 | Jardiance |
| Lilly USA, LLC | $27.82 | 2024-2025 | Mounjaro, Zepbound |
| Endotronix, INC. | $23.34 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Tactile Systems Technology INC | $20.54 | 2025 | Nimbl, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Chamorro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.